Canada's health minister soon may announce a series of steps to restrain wholesale shipment of prescription drugs to the U.S., including a ban on bulk exports, according to sources. Other possible actions include a more systematic drug-supply monitoring system and constraints on Canadian physicians who co-sign prescriptions for U.S. customers.

Related Summaries